tiprankstipranks
Advertisement
Advertisement
AbbVie: Hold Rating Reaffirmed as Skyrizi and Rinvoq Outperformance Potential Drives Price Target Increase to $244 Amid Ongoing Competitive and Pipeline Uncertainties
PremiumRatingsAbbVie: Hold Rating Reaffirmed as Skyrizi and Rinvoq Outperformance Potential Drives Price Target Increase to $244 Amid Ongoing Competitive and Pipeline Uncertainties
6d ago
Midday Fly By: Alphabet, Meta, Amazon, Microsoft report quarterly beats
Premium
The Fly
Midday Fly By: Alphabet, Meta, Amazon, Microsoft report quarterly beats
7d ago
AbbVie price target raised to $278 from $270 at Morgan Stanley
Premium
The Fly
AbbVie price target raised to $278 from $270 at Morgan Stanley
7d ago
AbbVie upgraded to Buy from Neutral at BofA
PremiumThe FlyAbbVie upgraded to Buy from Neutral at BofA
7d ago
AbbVie Earnings Call Highlights New Growth Leaders
Premium
Company Announcements
AbbVie Earnings Call Highlights New Growth Leaders
8d ago
Midday Fly By: Seagate reports Q3 beat, Visa reports mixed Q2
Premium
The Fly
Midday Fly By: Seagate reports Q3 beat, Visa reports mixed Q2
8d ago
Morning Movers: NXP Semi, Bloom Energy charged up after results
PremiumThe FlyMorning Movers: NXP Semi, Bloom Energy charged up after results
8d ago
AbbVie says ‘especially pleased’ with immunology and neuroscience results
Premium
The Fly
AbbVie says ‘especially pleased’ with immunology and neuroscience results
8d ago
AbbVie reports Q1 adjusted EPS $2.65, consensus $2.67
Premium
The Fly
AbbVie reports Q1 adjusted EPS $2.65, consensus $2.67
8d ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100